UBS Asset Management Americas Inc. raised its stake in National Health Investors Inc. (NYSE:NHI) by 9.1% during the second quarter, Holdings Channel reports. The fund owned 59,018 shares of the real estate investment trust’s stock after buying an additional 4,931 shares during the period. UBS Asset Management Americas Inc. owned 0.15% of National Health Investors worth $4,432,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Societe Generale purchased a new position in shares of National Health Investors during the second quarter valued at about $103,000. Creative Planning boosted its position in shares of National Health Investors by 2.6% in the second quarter. Creative Planning now owns 1,390 shares of the real estate investment trust’s stock valued at $104,000 after buying an additional 35 shares during the period. BNP Paribas Arbitrage SA boosted its position in shares of National Health Investors by 6,303.6% in the second quarter. BNP Paribas Arbitrage SA now owns 1,793 shares of the real estate investment trust’s stock valued at $135,000 after buying an additional 1,765 shares during the period. BlackRock Japan Co. Ltd boosted its position in shares of National Health Investors by 1.1% in the first quarter. BlackRock Japan Co. Ltd now owns 1,809 shares of the real estate investment trust’s stock valued at $120,000 after buying an additional 20 shares during the period. Finally, Huntington Asset Advisors Inc. purchased a new position in shares of National Health Investors during the first quarter valued at about $166,000. Hedge funds and other institutional investors own 67.49% of the company’s stock.
National Health Investors Inc. (NYSE:NHI) traded down 0.28% during mid-day trading on Friday, hitting $79.22. The stock had a trading volume of 61,516 shares. National Health Investors Inc. has a 52-week low of $54.51 and a 52-week high of $82.53. The stock has a market cap of $3.10 billion, a P/E ratio of 18.27 and a beta of 0.65. The firm has a 50-day moving average of $79.78 and a 200-day moving average of $73.17.
National Health Investors (NYSE:NHI) last announced its earnings results on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.01. The company had revenue of $61.20 million for the quarter, compared to analyst estimates of $58.08 million. National Health Investors had a return on equity of 14.68% and a net margin of 69.69%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.17 earnings per share. On average, analysts forecast that National Health Investors Inc. will post $4.88 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, November 10th. Shareholders of record on Friday, September 30th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.53%. The ex-dividend date of this dividend is Wednesday, September 28th. National Health Investors’s payout ratio is 82.95%.
Several research analysts recently issued reports on the company. Cantor Fitzgerald reissued a “hold” rating on shares of National Health Investors in a research note on Friday, September 9th. Wells Fargo & Co. reaffirmed a “hold” rating on shares of National Health Investors in a research report on Sunday, September 4th. Zacks Investment Research raised National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Mizuho increased their target price on National Health Investors from $66.00 to $77.00 and gave the company a “neutral” rating in a research report on Monday, August 8th. Finally, Stephens initiated coverage on National Health Investors in a research report on Wednesday, September 14th. They set an “overweight” rating and a $84.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $74.14.
In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, August 30th. The stock was sold at an average price of $80.29, for a total value of $64,232.00. Following the sale, the director now owns 10,021 shares of the company’s stock, valued at $804,586.09. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 5.74% of the stock is owned by company insiders.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc. (NYSE:NHI).
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.